Donald Mitchell

Donald Mitchell is the Vice President of Operations & Corporate Development at Spring Bank. Donald has held this position since October 2008. Prior to this, they were the Executive Director of Corporate Development at Idenix Pharmaceuticals from November 2007 to October 2008. From April 2005 to November 2007, they were the Senior Director of Marketing at Idenix Pharmaceuticals. From April 2004 to April 2005, they were the Director of Marketing at Amgen. From August 2002 to April 2004, they were the Director of Marketing for New Products at Amgen. From February 2001 to August 2002, they were the Director of Strategic Planning for the Anemia Business Unit at Amgen. From June 1999 to February 2001, they were the Associate Director of Marketing Business Analysis and Information at Amgen. Prior to joining Amgen, Donald Mitchell was a Principal Consultant at PricewaterhouseCoopers from January 1998 to June 1999. Donald was also the Director of Business Development at Novartis from December 1996 to December 1997.

Donald Mitchell has an MBA in marketing and finance from the University of Virginia Darden School of Business, as well as a BS in computer science from the United States Naval Academy.

Donald Mitchell reports to Martin Driscoll, Chairman, President & CEO. Some of their coworkers include Kevin Leach - Vice President, Nonclinical and Translational Research, Garrett Winslow - General Counsel, and R.P. Kris Iyer - Co-Founder, Chief Scientific Officer.